GRI Bio, Inc. (GRI) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 1K | 0 | 1K | 0 | 1K | 1K | 1K | 1K | 15K | 1K | 2K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | -1K | 0 | -1K | 0 | -1K | -1K | -1K | -1K | -15K | -1K | -2K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 0% | 100% | 0% | 100% | 93.33% | 0% | 50% | 0% | -15.38% | 0% | 88.24% |
| Operating Expenses | 2M | 2.66M | 3.37M | 2.9M | 3.05M | 1.95M | 2.13M | 2.26M | 1.89M | 2.01M | 2.44M | 5.93M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.64M | 1.03M | 1.6M | 1.02M | 1.41M | 1.12M | 999K | 1.38M | 961K | 965K | 1.25M | 5.05M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 361K | 1.63M | 1.77M | 1.88M | 1.64M | 829K | 1.13M | 877K | 933K | 1.05M | 1.19M | 880K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2M | -2.66M | -3.37M | -2.9M | -3.05M | -1.95M | -2.13M | -2.26M | -1.9M | -2.03M | -2.44M | -5.93M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 34.35% | -36.34% | -57.98% | -28.36% | -61% | 3.55% | 12.67% | 61.96% | -91.8% | -21.54% | -1211.29% | -3039.68% |
| EBITDA | -2M | -2.66M | -3.36M | -2.9M | -3.05M | -1.95M | -2.13M | -2.26M | -1.89M | -2.01M | -2.44M | -5.93M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 34.36% | -36.35% | -58.01% | -28.37% | -61.03% | 2.88% | 12.67% | 61.97% | -91.89% | -21.58% | -1217.84% | -3369.01% |
| D&A (Non-Cash Add-back) | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 15K | 1K | 2K |
| EBIT | -2M | -2.66M | -3.37M | -2.89M | -3.05M | -1.95M | -2.12M | -2.25M | -1.89M | -2M | -2.14M | -5.81M |
| Net Interest Income | 5K | 5K | 6K | 5K | 5K | 6K | 7K | 6K | 6K | 7K | 6K | -934K |
| Interest Income | 5K | 5K | 6K | 5K | 5K | 6K | 7K | 6K | 6K | 7K | 6K | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 934K |
| Other Income/Expense | 5K | 5K | 6K | 5K | 5K | 6K | 7K | 7K | 8K | 22K | 302K | -812K |
| Pretax Income | -2M | -2.66M | -3.36M | -2.89M | -3.05M | -1.95M | -2.12M | -2.25M | -1.89M | -2M | -2.14M | -6.75M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2M | -2.66M | -3.36M | -2.89M | -3.05M | -1.95M | -2.12M | -2.25M | -1.89M | -2M | -2.14M | -6.75M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 34.41% | -36.5% | -58.22% | -28.53% | -61.42% | 2.79% | 0.66% | 66.65% | 12.23% | 11.68% | -508.83% | -2186.78% |
| Net Income (Continuing) | -2M | -2.66M | -3.36M | -2.89M | -3.05M | -1.95M | -2.12M | -2.25M | -1.89M | -2M | -2.14M | -6.75M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.61 | -5.34 | -35.84 | -36.68 | -162.40 | -220.08 | -319.76 | -1731.80 | -2829.12 | -19204.08 | -22443.40 | -120858.64 |
| EPS Growth % | 99.01% | 97.57% | 88.79% | 97.88% | 94.26% | 98.85% | 98.58% | 98.57% | -112.83% | 87.41% | 79.76% | 73.16% |
| EPS (Basic) | -1.61 | -5.34 | -35.84 | -36.68 | -162.40 | -220.08 | -319.76 | -1731.80 | -2829.12 | -19204.08 | -22443.40 | -120858.64 |
| Diluted Shares Outstanding | 1.24M | 497.7K | 93.63K | 78.75K | 18.77K | 6.55K | 6.64K | 16.35K | 11.34K | 1.77K | 1.62K | 949 |
| Basic Shares Outstanding | 1.24M | 497.7K | 93.63K | 78.75K | 18.77K | 6.55K | 6.64K | 16.35K | 11.34K | 1.77K | 1.62K | 949 |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |